Grune Jana, Blumrich Annelie, Brix Sarah, Jeuthe Sarah, Drescher Cathleen, Grune Tilman, Foryst-Ludwig Anna, Messroghli Daniel, Kuebler Wolfgang M, Ott Christiane, Kintscher Ulrich
Institute of Pharmacology, Center for Cardiovascular Research, Charité -Universitaetsmedizin Berlin, Hessische Str. 3-4, 10115, Berlin, Germany.
German Center for Cardiovascular Research (DZHK), partner site Berlin, 10117, Berlin, Germany.
Cardiovasc Ultrasound. 2018 Jul 3;16(1):10. doi: 10.1186/s12947-018-0128-9.
The assessment of ventricular volumes using conventional echocardiography methods is limited with regards to the need of geometrical assumptions. In the present study, we aimed to evaluate a novel commercial system for three-dimensional echocardiography (3DE) in preclinical models by direct comparison with conventional 1D- and 2D-echocardiography (1DE; 2DE) and the gold-standard technique magnetic resonance imaging (MRI). Further, we provide a standard operating protocol for image acquisition and analysis with 3DE.
3DE was carried out using a 30 MHz center frequency transducer coupled to a Vevo®3100 Imaging System. We evaluated under different experimental conditions: 1) in vitro phantom measurements served as controlled setting in which boundaries were clearly delineated; 2) a validation cohort composed of healthy C57BL/6 J mice and New Zealand Obese (NZO) mice was used in order to validate 3DE against cardiac MRI; 3) a standard mouse model of pressure overload induced-heart failure was investigated to estimate the value of 3DE.
First, in vitro volumetry revealed good agreement between 3DE assessed volumes and the MRI-assessed volumes. Second, cardiac volume determination with 3DE showed smaller mean differences compared to cardiac MRI than conventional 1DE and 2DE. Third, 3DE was suitable to detect reduced ejection fractions in heart failure mice. Fourth, inter- and intra-observer variability of 3DE showed good to excellent agreement regarding absolute volumes in healthy mice, whereas agreement rates for the relative metrics ejection fraction and stroke volume demonstrated good to moderate observer variabilities.
3DE provides a novel method for accurate volumetry in small animals without the need for spatial assumptions, demonstrating a technique for an improved analysis of ventricular function. Further validation work and highly standardized image analyses are required to increase reproducibility of this approach.
使用传统超声心动图方法评估心室容积时,由于需要几何假设而受到限制。在本研究中,我们旨在通过与传统的一维和二维超声心动图(1DE;2DE)以及金标准技术磁共振成像(MRI)直接比较,评估一种用于临床前模型的新型三维超声心动图(3DE)商业系统。此外,我们提供了使用3DE进行图像采集和分析的标准操作方案。
使用与Vevo®3100成像系统耦合的30MHz中心频率换能器进行3DE。我们在不同的实验条件下进行评估:1)体外模型测量作为对照设置,其中边界清晰划定;2)使用由健康的C57BL/6J小鼠和新西兰肥胖(NZO)小鼠组成的验证队列,以便针对心脏MRI验证3DE;3)研究压力超负荷诱导心力衰竭的标准小鼠模型,以评估3DE的价值。
首先,体外容积测量显示3DE评估的容积与MRI评估的容积之间具有良好的一致性。其次,与传统的1DE和2DE相比,3DE测定心脏容积与心脏MRI的平均差异更小。第三,3DE适用于检测心力衰竭小鼠射血分数降低。第四,3DE的观察者间和观察者内变异性在健康小鼠的绝对容积方面显示出良好到极好的一致性,而射血分数和每搏输出量等相对指标的一致性率显示出良好到中等的观察者变异性。
3DE提供了一种无需空间假设即可在小动物中进行准确容积测量的新方法,证明了一种改进心室功能分析的技术。需要进一步的验证工作和高度标准化的图像分析来提高这种方法的可重复性。